Brookings Biomedical Profile last edited on: 12/23/2014
CAGE: 5MUA5
UEI:
Business Identifier: NO Business Identifier is currently available for this company. 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 00
County: Brookings
Congr. District: 00
County: Brookings
Public Profile
Brookings Biomedical's goal is to construct a multi-pathogen vaccine based on intestinal immune stimulation driven by LT as an adjuvant.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
1-4Revenue Range
Less than .5MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
N/AAwards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 2011 | 1 | USDA | $100,000 | |
| Project Title: Development of a simple killed enterotoxigenic E. coli vaccine for weaned pigs | ||||
| 2010 | 1 | USDA | $90,000 | |
| Project Title: Multivalent Mucosal Vaccine to Include Swine Influenza | ||||
Key People / Management
Todd Gunn -- President
Mojun Zhao -- Senior Scientist
Mojun Zhao -- Senior Scientist
Company News
There are no news available.
